newsfilter
← Latest News
GlobeNewswire·

InflaRx to Report First Quarter 2026 Results on May 7, 2026

JENA, Germany, May 01, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (NASDAQ:IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the Company